BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25557623)

  • 1. Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo delivery.
    Cooney AL; Singh BK; Sinn PL
    Mol Ther; 2015 Apr; 23(4):667-74. PubMed ID: 25557623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel AAV-mediated Gene Delivery System Corrects CFTR Function in Pigs.
    Cooney AL; Thornell IM; Singh BK; Shah VS; Stoltz DA; McCray PB; Zabner J; Sinn PL
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):747-754. PubMed ID: 31184507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac/adenovirus.
    Cooney AL; Singh BK; Loza LM; Thornell IM; Hippee CE; Powers LS; Ostedgaard LS; Meyerholz DK; Wohlford-Lenane C; Stoltz DA; B McCray P; Sinn PL
    Nucleic Acids Res; 2018 Oct; 46(18):9591-9600. PubMed ID: 30165523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
    Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
    PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors.
    Teramoto S; Bartlett JS; McCarty D; Xiao X; Samulski RJ; Boucher RC
    J Virol; 1998 Nov; 72(11):8904-12. PubMed ID: 9765435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
    Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
    Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
    Flotte TR; Afione SA; Conrad C; McGrath SA; Solow R; Oka H; Zeitlin PL; Guggino WB; Carter BJ
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10613-7. PubMed ID: 7504271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient CFTR expression from AAV vectors packaged with promoters--the second generation.
    Wang D; Fischer H; Zhang L; Fan P; Ding RX; Dong J
    Gene Ther; 1999 Apr; 6(4):667-75. PubMed ID: 10476227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
    Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
    Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo.
    Keravala A; Liu D; Lechman ER; Wolfe D; Nash JA; Lampe DJ; Robbins PD
    Hum Gene Ther; 2006 Oct; 17(10):1006-18. PubMed ID: 16989604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
    Conrad CK; Allen SS; Afione SA; Reynolds TC; Beck SE; Fee-Maki M; Barrazza-Ortiz X; Adams R; Askin FB; Carter BJ; Guggino WB; Flotte TR
    Gene Ther; 1996 Aug; 3(8):658-68. PubMed ID: 8854091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system.
    Cunningham SC; Siew SM; Hallwirth CV; Bolitho C; Sasaki N; Garg G; Michael IP; Hetherington NA; Carpenter K; de Alencastro G; Nagy A; Alexander IE
    Hepatology; 2015 Aug; 62(2):417-28. PubMed ID: 26011400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
    White AF; Mazur M; Sorscher EJ; Zinn KR; Ponnazhagan S
    Hum Gene Ther; 2008 Dec; 19(12):1407-14. PubMed ID: 18778196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.
    Sirninger J; Muller C; Braag S; Tang Q; Yue H; Detrisac C; Ferkol T; Guggino WB; Flotte TR
    Hum Gene Ther; 2004 Sep; 15(9):832-41. PubMed ID: 15353038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.
    Kearns WG; Afione SA; Fulmer SB; Pang MC; Erikson D; Egan M; Landrum MJ; Flotte TR; Cutting GR
    Gene Ther; 1996 Sep; 3(9):748-55. PubMed ID: 8875221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.
    Li W; Zhang L; Johnson JS; Zhijian W; Grieger JC; Ping-Jie X; Drouin LM; Agbandje-McKenna M; Pickles RJ; Samulski RJ
    Mol Ther; 2009 Dec; 17(12):2067-77. PubMed ID: 19603002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.